This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Familial defective apoprotein B-100

Authoring team

In this genetic hyperlipidaemia cholesterol levels are raised (usually cholesterol 7.5-16 mmol/L) and triglyceride levels are below 2.3 mmol/L. LDL-cholesterol is increased.

In this condition a mutation of apo B interferes with binding of LDL. The most common cause of this condition is due to a substitution of an amino-acid at position 3500. This mutation has an incidence of approximately 1 in 600 in the general population although it generally does not produce an especially severe hyperlipidaemia.

This is an example of a type IIa hyperlipidaemia according to the Who/Fredrickson classification of primary hyperlipidaemias.

Clinical features are similar to those seen in familial hypercholesterolaemia (FH).

It has been estimated that up to 4% of patients with clinical FH may have familial defective apo B.

Reference

  1. Anderson L et al. Familial defective apolipoprotein B-100: A review. Journal of Clinical Lipidology. Volume 10, Issue 6. p1297-1302. November-December, 2016

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.